linjc16/ctgov huggingface dataset:
COVID-19 Induced Telogen Effluvium

Study Overview
=================
Brief Summary
-----------------
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Detailed Description
-----------------
Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.

Official Title
-----------------
COVID-19 Induced Telogen Effluvium

Conditions
-----------------
Covid19, Telogen Effluvium, SARS-CoV Infection, Alopecia

Intervention / Treatment
-----------------
* Diagnostic Test: Blood Tests


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Sars-CoV-2 infection in the past year Exclusion Criteria: Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: Blood Tests|Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Hair shedding | Physical examination of hair and scalp, trichoscopy, hair pull test | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Telogen Effluvium, Covid-19, Alopecia
Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

Study Overview
=================
Brief Summary
-----------------
The aim of this proposal is to examine whether endogenous GIP and exogenous GIP alone and in combination with insulin affect gastric emptying (GE), appetite, energy intake, energy expenditure (EE) and plasma levels of triglycerides (TAG), free fatty acids FFA) and glycerol in man.

Official Title
-----------------
On the Role of Glucose-dependent Insulinotropic Polypeptide, GIP, in Postprandial Metabolism in Humans

Conditions
-----------------
Healthy Subjects

Intervention / Treatment
-----------------
* Other: Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Informed oral and written consent Caucasians over the age of 18 years Normal 75 g oral glucose tolerance test (OGTT) Normal blood haemoglobin concentration Normal plasma lipid profile Exclusion Criteria: First-degree relatives with diabetes and familial hypertriglyceridemia

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Healthy subjects<br>30 healthy subjects without family history of diabetes or gastrointestinal disease, a normal oral glucose tolerance test (OGTT) and no intake of medicine | Other: Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)<br>* two different dosages: 0.8 pmol/kg/min 1.5 pmol/kg/min for 300 minutes<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Glucose-dependent insulinotropic polypeptide, gastric emptying, appetite, energy intake, lipid metabolism
Self-correction Evaluation in Scoliosis Patients

Study Overview
=================
Brief Summary
-----------------
To date, there is no objective assessment method for the quality of the self-correction performed by patients with scoliosis. The study consists of two parts, both retrospective, and distinct on the basis of the tools used to assess self-correction. Part 1: Retrospective assessment of the radiographic variations between spontaneous position and self-correction in subjects suffering from juvenile and adolescent idiopathic scoliosis. Both measurements were performed in a single session. Part 2: Retrospective assessment of the variations between spontaneous and self-correcting position in subjects with juvenile and adolescent idiopathic scoliosis using objective parameters deriving from non-invasive 3D ultrasound instrumentation (Scolioscan, Telefeld, Hong Kong).

Official Title
-----------------
Instrumental Evaluation of Self-correction in Patients With Juvenile and Adolescent

Conditions
-----------------
Scoliosis; Juvenile, Scoliosis; Adolescence

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria for both parts: Diagnosis of juvenile or adolescent idiopathic scoliosis; Age >= 10 years; Single and double curves with amplitude >= 15 ° Cobb; Performing exercises according to SEAS for at least 6 months Only for part 1 (radiographic) Availability of radiographic investigation in upright position and in self-correction Only for part 2 (ultrasound) Availability of ultrasound assessment in upright position and in self-correction Complete radiograph of the spine in anteroposterior projection performed in the 45 days preceding or following the medical examination. Risser between 0 and 2. Exclusion Criteria: For both parts: Patients with more than 2 scoliotic curves Patients with secondary scoliosis Patients suffering from learning disabilities or clinical conditions impairing neuromotor control Patients lacking the necessary measures to evaluate the outcome. Part 2 only (ultrasound) ● Patients undergoing brace treatment

Ages Eligible for Study
-----------------
Minimum Age: 10 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Ultrasound assessment<br>Quantitative comparison between ultrasound images performed in active self-correction and in a spontaneous position | |
| RX assessment<br>Quantitative comparison between radiological images performed in active self-correction and in a spontaneous position | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Self-correction measure | The angular difference of the curves resulting from the detection with Scolioscan or Rx in the spontaneous position compared to what was obtained in the same condition but in the self-correcting position. | through study completion, an average of 6 months |
A Comparison of Two Psycho-educational Group Interventions for Tinnitus Patients

Study Overview
=================
Brief Summary
-----------------
participants will be randomized into one of three groups: 3-session CET intervention, 3-session ACT intervention, or Waiting List group. Each weekly session will last up to 2 hours and 10 participants will be assigned to each group. There will be two cohorts, with 30 participants in each cohort. The Waiting List group will receive the CET intervention after the groups have completed theirs.

Official Title
-----------------
A Comparison of Two Psycho-educational Group Interventions for Tinnitus Patients

Conditions
-----------------
Tinnitus

Intervention / Treatment
-----------------
* Other: ACT
* Other: CET


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Tinnitus lasting more than 3 months Hebrew speaking Use hearing aids if needed Signed informed consent Exclusion Criteria: None

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: CET<br>CET - Coping Effectiveness Training group. | Other: CET<br>* Psycho-educational group<br>|
| Experimental: ACT<br>ACT - Acceptance and Commitment Therapy group | Other: ACT<br>* Psycho-educational group<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| COPE | Coping scale questionnaire | Before the intervention (T1) and at the end of intervention (T2-4 weeks after T1), 1 month after end of intervention (T3) |
Variation of Progesterone in IVF Cycles

Study Overview
=================
Brief Summary
-----------------
to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.

Detailed Description
-----------------
The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators.

Official Title
-----------------
Variation of Progesterone in IVF Cycles

Conditions
-----------------
Progesterone Resistance

Intervention / Treatment
-----------------
* Diagnostic Test: Progesterone variation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients 18-45 years BMI 18-35 kg/m2 Menstrual cycle length 24-35 days Stimulation with rFSH or hMG Exclusion Criteria: None

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: Progesterone variation|The potential gain for medical caretakers and patients would be a certainty if the progesterone level is affected by variations during daytime|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The variation of serum progesterone around the ovulation triggering in IVF-cycles | the circadian secretion-pattern of progesterone during early follicular phase of normal cycling females | 6-8 months |
Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis.

Study Overview
=================
Brief Summary
-----------------
This study will provide an educational intervention through means of a video to educate subjects on the risk of cardiovascular health on Rheumatoid arthritis.

Detailed Description
-----------------
Subjects will be randomized into an interventional group and non-interventional group. Both groups will perform several surveys before an educational intervention may be given. Both Groups will come back 3 months post visit to complete additional surveys.

Official Title
-----------------
Web (YouTube) Based Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis.

Conditions
-----------------
Rheumatoid Arthritis, Arthritis, Rheumatoid

Intervention / Treatment
-----------------
* Other: YouTube Video


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Clinical Diagnoses of Rheumatoid Arthritis of at least 3 months by a Rheumatologist Exclusion Criteria: Inability to communicate in English.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: EI development phase.<br> | Other: YouTube Video<br>* Educational Video<br>|
| No Intervention: Pilot-testing phase.<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Heart Disease Knowledge Questionnaire | 30 items survey completed at baseline (pre-intervention, post intervention), and 3 month follow-up. Change in cardiovascular knowledge at 3 months and baseline (post-intervention) will be measured against baseline pre-intervention values. | 3 Months | 
| Heart Disease Fact Questionnaire | 13 items survey completed at baseline (pre-intervention, post intervention), and 3 month follow-up. Change in cardiovascular awareness at 3 months and baseline (post-intervention) will be measured against baseline pre-intervention values. | 3 Months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Statues of Hyperlipidemia treatment | Change in hyperlipidemia treatment from Screening to 1 year. | 1 Year | 
| Cholesterol | Change in Cholesterol from Screening to 1 year. | 1 year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
RA, Rheumatoid Arthritis, Arthritis
Ideal Point of Transluminal Light in Tracheal Intubation With a Light Wand

Study Overview
=================
Brief Summary
-----------------
If the patients's teeth are weak or the mouth dose not open well, the lightwand is a useful device when endotracheal intubation is necessary. Therefore, if the appropriate position of the light beam is determined and the distance of the light source suitable for intubation using the lightwand is obtained from anatomical structures such as thyroid cartilage and cricoid cartilage, it is clinically useful. Because it can prevent unnecessary deep insertion or shallow insertion that can cause damage to anatomical structures during intubation.

Detailed Description
-----------------
Studies have been reported on the proper position to bend the lightwand and the appropriate angle to bend when performing endotracheal intubation with lightwand. For ease of procedure, the assistant has to lift the patient's lower jaw or perform a neck extension. However, there is no report on the position of the lightbulb when the light passes through the front of the airway and neck and appears bright in the midpoint. The prodcedure is as follows. FOB examination and check position of light below 1cm from vocal cord lightwand intubation aimed at checkpoint measurement of distance from thyroid cartilage/cricoid cartilage to light point

Official Title
-----------------
Ideal Point of Transluminal Light in Tracheal Intubation With a Light Wand

Conditions
-----------------
Neck Disease, Trismus, Tooth Abnormalities

Intervention / Treatment
-----------------
* Procedure: lightwand intubation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: impossibility of neck extension trismus weak teeth Exclusion Criteria: previous history of larynx or neck surgery no informed consent

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Procedure: lightwand intubation|intubation using lightwand|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| distance from lightbeam of the FOB to thyroid cartilage | we will measure straight distance from lightbeam of the FOB to thyroid cartilage on the surface of patient's neck | before intubation | 
| distance from lightbeam of the FOB to cricoid cartilage | we will measure straight distance from lightbeam of the FOB to cricoid cartilage on the surface of patient's neck | before intubation | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| distance from lightbeam of the FOB to sternal notch | we will measure straight distance from lightbeam of the FOB to sternal notch on the surface of patient's neck | before intubation |
Nutrition and Physical Exercise Study

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to investigate the effect of a combined treatment of nutritional therapy and physical exercise in palliative cancer out-patients. The investigators hypothesize that this combined intervention consisting of an increased energy- and protein intake and physical exercise level improves quality of life (QoL), functional and clinical status.

Official Title
-----------------
Influence of a Combined Intervention by Nutritional Support and Physical Exercise on Quality of Life in Cancer Out-patients Treated in Palliative Intention.

Conditions
-----------------
Gastrointestinal Cancer, Lung Cancer

Intervention / Treatment
-----------------
* Behavioral: Nutrition & physical exercise


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Histologically or cytologically confirmed metastatic lung cancer or gastrointestinal cancer WHO performance status 0, 1 or 2 Able to walk at least 100 meters independently without crutches or walking frame assessed by the treating physician on the basis of the patient's history and physical condition Receiving palliative treatment Exclusion Criteria: Enteral and/or parenteral nutrition within 1 month previous to study participation History of ileus within one month Known brain metastases or symptomatic bone metastases Psychiatric disorder precluding understanding of information on trial related topics and giving informed consent. Any serious underlying medical condition which could impair the ability of the patient to participate in the trial

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Nutrition & physical exercise<br> | Behavioral: Nutrition & physical exercise<br>* Patients will be randomly assigned to intensive individual nutritional counselling including oral nutritional supplements and a specifically designed exercise program combining strength and balance training.<br>|
| No Intervention: Control<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Quality of life |  | 3 months |
Evaluation and Validation of New Biomarkers by Mass Spectrometry

Study Overview
=================
Brief Summary
-----------------
The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.

Official Title
-----------------
A New Approach by Mass Spectrometry for Evaluation and Validation of New Biomarkers of Fetus and Mother

Conditions
-----------------
Diabetes Mellitus

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For women: Aged 18 or more 24 weeks of gestation or more Type 1, type 2 or gestational diabetes mellitus for group 1 Without diabetes for group 2. For newborn: 37 weeks of gestation or more Birth weight 2500 g or more Exclusion Criteria: Multiple birth

Ages Eligible for Study
-----------------
Minimum Age: 1 Day

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Diabetes Mellitus<br>Patients with type 1, type 2 or gestational diabetes mellitus | |
| Normal pregnancy<br>Patient without diabetes mellitus | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Foetal HbA1c |  | At delivery | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Foetal acetylated Hb |  | At delivery |
The Hybrid Combination of CCTA and SPECT and CAG for Evaluation Prognosis of CAD: an Observational Follow-up Study

Study Overview
=================
Brief Summary
-----------------
A total of 550 patients with stable angina (40-70% stenosis) tested by coronary CT angiography (CCTA) and single photon emission computed tomography (SPECT) and coronary angiography (CAG) within 3 months were retrospectively recruited from 2005 to 2015 and follow up to 5 years. A new hybrid software was used to analysis the image data.

Official Title
-----------------
The First Affiliated Hospital of Nanjing Medical University

Conditions
-----------------
Coronary Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age: 18-70 Gender: All coronary artery disease patients (CAD) underwent CCTA, SPECT and coronary angiography (CAG) together within 3 months Time: 2005-2015 Exclusion Criteria: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), congenital heart disease (CHD), atrial fibrillation (AF), ventricular tachycardia (VT) Prior coronary revascularization; permanent pacemaker or internal defibrillator prosthetic heart valve coronary image lose coronary artery severe calcification motion artifacts and poor CCTA image quality

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Major adverse cardiac events (MACE) | All-cause death, cardiac death, ischemic stroke, unplanned revascularization and nonfatal myocardial infarction | 5 YEARS | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
SPECT, CCTA, CAG, Hybrid